Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2013 | 10-2012 | 07-2012 | 04-2012 | 01-2012 | |
| Sales | 0 | -7 | 250 | 248 | 449 |
| Cost of Goods | N/A | N/A | 1 | 1 | 1 |
| Gross Profit | N/A | -5 | 249 | 248 | 449 |
| Operating Expenses | 2,073 | 1,719 | 893 | 1,126 | 1,337 |
| Operating Income | -2,073 | -1,726 | -643 | -878 | -887 |
| Interest Expense | 22 | 0 | 0 | 0 | 0 |
| Other Income | 0 | -135 | 14 | 1 | 1 |
| Pre-tax Income | -2,095 | -1,861 | -629 | -877 | -886 |
| Net Income Continuous | -2,095 | -1,861 | -629 | -877 | -886 |
| Net Income | $-2,095 | $-1,861 | $-629 | $-877 | $-886 |
| EPS Basic Total Ops | -0.25 | N/A | 0.00 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.28 | -0.25 | -0.09 | -0.12 | -0.12 |
| EPS Diluted Total Ops | -0.25 | N/A | 0.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.28 | -0.25 | -0.09 | -0.12 | -0.12 |
| EBITDA(a) | $-2,068 | $-1,726 | $-643 | $-878 | $-885 |